Navigation Links
First Prostate Cancer Registry for Robotic Radiosurgery Patients Enrolls More than 500 Men
Date:9/30/2011

MIAMI, Sept. 30, 2011 /PRNewswire/ -- The CyberKnife Coalition announced today that more than 500 men treated with the CyberKnife Robotic Radiosurgery System® have now been enrolled in the first national patient registry designed specifically to track prostate cancer patients treated with stereotactic body radiation therapy. The multi-institutional Registry for Prostate Cancer Radiosurgery (RPCR), tracks clinical and functional outcomes of men with localized prostate cancer treated at academic and community based centers throughout the U.S.

Launched in July 2010, the RPCR is an independent IRB-approved observational trial registered with clinicaltrials.gov designed to collect information that will be useful in determining the role of radiosurgical treatment for patients with early-stage prostate cancer. In addition to tracking clinical data the registry also collects patient selection and quality of life information, which will be reported to the Centers for Medicare & Medicaid Services (CMS) and local Medicare contractors.

"We're excited to see such a positive response to the registry," said Mark Perman, M.D., CyberKnife Coalition board member, co-founder of the RPCR and member of South Florida Radiation Oncology. "The RPCR continues to grow rapidly and we are on track to have 20 centers participating by the end of this year.  I anticipate that the registry will become a mechanism for clinicians to measure the quality of the care they provide against a national benchmark of community-based and academic radiosurgery centers and will help fill in the evidence gaps pertaining to prostate radiation."  

Based on its strong belief in the need for the collection of clinical and patient-focused quality of life data for the therapies we offer our patients, the CyberKnife Coalition encourages participation of its membership to join the RPCR. The registry's ability to track real world data allows our members to make a meaningful contribution to the growing body of clinical research and helps to fill evidence gaps across the entire field of radiation.

"With more than 500 patients now enrolled, the RPCR has taken a significant step in building the most comprehensive data source on robotic radiosurgery for prostate cancer," said Linda Winger, president, the CyberKnife Coalition.

By participating in the registry, CyberKnife centers will be better equipped to help patients make the best decision for their individual circumstances, a view that is shared by the Agency for Healthcare Quality and Research who earlier this month published a patient guide entitled 'Knowing your Treatment Options', an overview of prostate cancer treatment options, that for the first time included SBRT as an treatment option for men with localized prostate cancer.

CyberKnife Coalition

Formed in May 2003 as an informal organization of CyberKnife facilities and formally incorporated in April 2005, the CyberKnife Coalition, Inc. (CKC) is a non-profit [501(c) 6] association of hospitals and freestanding centers across the United States committed to improving patient access to image-guided robotic stereotactic radiosurgery.  The CKC membership includes major academic institutions as well as community hospitals and clinics. All CKC member centers offer image-guided robotic stereotactic radiosurgery to treat malignant and benign tumors and other select disorders with high dose, precisely targeted radiation.


'/>"/>
SOURCE CyberKnife Coalition
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from PsychTests.com reveals that behind the tendency to set low ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
Breaking Medicine News(10 mins):